Castleark Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,660
Closed -$114K 348
2021
Q3
$114K Hold
1,660
﹤0.01% 313
2021
Q2
$140K Hold
1,660
﹤0.01% 313
2021
Q1
$135K Sell
1,660
-890
-35% -$76K ﹤0.01% 313
2020
Q4
$222K Hold
2,550
0.01% 307
2020
Q3
$229K Hold
2,550
0.01% 309
2020
Q2
$265K Buy
+2,550
New +$246K 0.01% 290
2020
Q1
Sell
-6,420
Closed -$561K 361
2019
Q4
$561K Buy
+6,420
New +$548K 0.02% 278
2015
Q3
Sell
-47,425
Closed -$4.94M 384
2015
Q2
$4.94M Sell
47,425
-16,550
-26% -$1.71M 0.13% 183
2015
Q1
$5.86M Buy
63,975
+18,350
+40% +$1.52M 0.14% 172
2014
Q4
$3.34M Buy
+45,625
New +$2.98M 0.09% 194
2014
Q1
Sell
-8,500
Closed -$430K 321
2013
Q4
$430K Buy
+8,500
New +$370K 0.01% 283

Other funds holding INCY

Castleark Management's INCY Position: Q4 2021 in Review

Castleark Management sold out of Incyte (INCY) in Q4 2021, closing a stake of 1,660 shares — an estimated $114K sold.

Castleark Management first reported a position in INCY in Q4 2013 and held it in 11 quarters. The position peaked at $5.86M in Q1 2015. 526 funds tracked by Wall St. Rank hold INCY as of Q4 2021.

  • Castleark Management reported no remaining Incyte position as of Q4 2021 after selling out during the quarter.
  • Castleark Management sold 1,660 Incyte shares in Q4 2021, an estimated $114K.
  • Castleark Management first reported a position in Incyte in Q4 2013 and held it in 11 quarters.
  • Castleark Management's Incyte position peaked at $5.86M in Q1 2015.
  • 526 funds tracked by Wall St. Rank held Incyte as of Q4 2021.

Based on Castleark Management's 13F filing for Q4 2021, filed 16 Feb 2022.